Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of <sup>68</sup>Ga-PSMA and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients

Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of <sup>68</sup>Ga-PSMA and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients

The aim of the present study is to investigate the synergic role of <sup>68</sup>Ga-PSMA PET/MRI and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in prostate cancer (PCa) staging. We present pilot data on twenty-two patients with biopsy-proven PCa that underwent <sup>68</sup>...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Paola Mapelli, Samuele Ghezzo, Ana Maria Samanes Gajate, Erik Preza, Giorgio Brembilla, Vito Cucchiara, Naghia Ahmed, Carolina Bezzi, Luca Presotto, Valentino Bettinardi, Annarita Savi, Patrizia Magnani, Raffaele Menichini, Angela Coliva, Ilaria Neri, Ettore Di Gaeta, Luigi Gianolli, Massimo Freschi, Alberto Briganti, Francesco De Cobelli, Paola Scifo, Maria Picchio
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
hybrid imaging
PET/MRI
PSMA
RM2
prostate cancer
multimodal imaging
Medicine (General)
R5-920
Accès en ligne:https://doaj.org/article/4ecd835d579a4984862cb5adb3863929
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/4ecd835d579a4984862cb5adb3863929

Documents similaires